Trials / Active Not Recruiting
Active Not RecruitingNCT04830228
BIOTRONIK Dynetic-35 Stent for the Treatment of Peripheral Iliac Lesions
BIOTRONIK Dynetic-35 for the Treatment of Peripheral Iliac Lesions, Using the Cobalt Chromium Balloon-expandable Dynetic-35 Stent in Association With Passeo-35 Xeo Peripheral Dilation Catheter
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 160 (actual)
- Sponsor
- Biotronik AG · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
BIOTRONIK cobalt chromium balloon-expandable Dynetic-35 stent in association with Passeo-35 Xeo peripheral dilation catheter for the treatment of peripheral iliac lesions
Detailed description
Prospective, international, multi-center, single-arm study with up to 60 months follow up to evaluate safety and effectiveness of BIOTRONIK's Dynetic-35 stent associated with the use of Passeo-35 Xeo for the treatment of peripheral artery disease (PAD) in subjects with atherosclerotic disease in iliac arteries
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Ballon expandable stent and PTA | Endovascular treatment for the peripheral artery disease of the Iliac artery |
Timeline
- Start date
- 2021-08-10
- Primary completion
- 2023-02-28
- Completion
- 2028-02-28
- First posted
- 2021-04-05
- Last updated
- 2023-12-12
Locations
15 sites across 6 countries: Austria, Belgium, France, Germany, Hungary, Latvia
Source: ClinicalTrials.gov record NCT04830228. Inclusion in this directory is not an endorsement.